Breaking News Instant updates and real-time market news.

AAPL

Apple

$148.98

-6.01 (-3.88%)

, HNHPF

Hon Hai Precision

06:27
06/12/17
06/12
06:27
06/12/17
06:27

Foxconn CEO says Apple, Dell part of Toshiba chip bid, Reuters says

Apple (AAPL), Dell and Kingston Technology are part of Foxconn's (HNHPF) bid for Toshiba's (TOSYY, TOSBF) chip unit, Reuters reports, citing an interview with Terry Gou, Foxconn founder and CEO. Gou said Amazon (AMZN) is also close to joining the bid and the company is in talks with Google (GOOG, GOOGL), Microsoft (MSFT) and Cisco (CSCO) about potentially participating. Reference Link

AAPL

Apple

$148.98

-6.01 (-3.88%)

HNHPF

Hon Hai Precision

TOSYY

Toshiba, also use TOSBF

$16.23

0.41 (2.59%)

TOSBF

Toshiba, also use TOSYY

$2.71

0.07 (2.65%)

AMZN

Amazon.com

$978.31

-31.96 (-3.16%)

GOOG

Alphabet

$949.83

-33.58 (-3.41%)

GOOGL

Alphabet Class A

$970.12

-34.16 (-3.40%)

MSFT

Microsoft

$70.32

-1.63 (-2.27%)

CSCO

Cisco

$31.37

-0.24 (-0.76%)

  • 12

    Jun

  • 12

    Jun

  • 20

    Jun

  • 21

    Jun

  • 22

    Jun

  • 28

    Jun

  • 12

    Jul

  • 19

    Jul

AAPL Apple
$148.98

-6.01 (-3.88%)

06/06/17
COWN
06/06/17
NO CHANGE
Target $60
COWN
Outperform
Criteo stock reaction after Apple developer conference overdone, says Cowen
Cowen analyst Thomas Champion noted Criteo (CRTO) shares were under pressure following comments from the Apple (AAPL) developer conference yesterday, but he believes exposure to the desktop Safari browser seems limited, which will mitigate risk to revenue, suggesting the stock reaction is overdone. Champion reiterated his Outperform rating on Criteo shares.
06/07/17
RBCM
06/07/17
NO CHANGE
RBCM
Analog Devices weakness will be short lived, says RBC Capital
RBC Capital analyst Amit Daryanani notes that Analog Devices (ADI) "has underperformed rather notably" since its Q2 results on May 31. The analyst blames the weakness on the company's reduced revenue from Apple (AAPL). However, he thinks that investors will begin focusing more on the company's multiple tailwinds, possibly starting in the wake of its June 20 Analyst Day. Consequently, he expects the stock to rise from current levels and keeps a $92 price target and Outperform rating on the shares.
06/07/17
ARGS
06/07/17
NO CHANGE
ARGS
Apple price target raised to $175 from $160 at Argus
Argus analyst Jim Kelleher increased his price target on Apple after the company annoucned new products and product enhancements. The analyst quotes Apple bears as saying that the company is "playing catch-up" by introducing similar products to those that its rivals have already launched. However, Kelleher says that, "coming late to the party did not hurt iPhone's leadership in smartphones." He keeps a Buy rating on the shares. .
06/11/17
MZHO
06/11/17
DOWNGRADE
Target $150
MZHO
Neutral
Apple downgraded to Neutral from Buy at Mizuho
Mizuho analyst Abhey Lamba downgraded Apple to Neutral from Buy and lowered his price target for the shares to $150 from $160. The iPhone maker fell along with the Nasdaq index late in Friday's trade to close down 4%, or $6.01, to $148.98. "Enthusiasm" around the upcoming iPhone launch is fully priced in after the stock's year-to-date outperformance, Lamba wrote to investors Sunday night. The analyst sees limited upside to consensus estimates and notes Apple shares are trading near the upper-end of their recent valuation range.
HNHPF Hon Hai Precision

TOSYY Toshiba, also use TOSBF
$16.23

0.41 (2.59%)

02/27/17
MAXM
02/27/17
NO CHANGE
Target $11
MAXM
Buy
Vuzix smart glasses pact with Toshiba a pivotal event, says Maxim
Maxim analyst Brian Kinstlinger noted that Toshiba's (TOSBF) pact with Vuzix (VUZI) for a custom pair of smart glasses based on the recent M300s comes just a year after Toshiba canceled the release of their Wearvue smart glasses and views the deal as validation that Vuzix is a "clear leader" in smart glasses technology. The analyst, who sees the development agreement as a pivotal event for Vuzix, suggests investors buy Vuzix shares ahead of the ramp in revenues he expects in 2017 and reiterates a Buy rating and $11 price target on the stock.
05/18/17
UBSW
05/18/17
NO CHANGE
Target $21
UBSW
Buy
Marvell shares will outperform when company addresses trends, says UBS
UBS analyst Stephen Chin laid out three reasons why he still likes Marvell (MRVL) shares. He cited its strong balance sheet and a decision on either a big buyback or an acquisition soon; expectations for storage sales to continue to grow; and his view that the concerns about the possibility of a competitor buying Toshiba's (TOSBF) memory assets are overblown. The analyst feels Marvell's valuation remains attractive and once the company addresses concerns about fundamental trends in storage, the stock should outperform. Chin maintained his Buy rating and $21 price target on Marvell shares.
03/31/17
UBSW
03/31/17
NO CHANGE
Target $245
UBSW
Buy
Broadcom deal for Toshiba NAND has wide range of accretion potential, says UBS
UBS analyst Stephen Chin commented on the Nikkei report that Broadcom (AVGO) and Silver Lake Partners had submitted a bid to acquire Toshiba's (TOSBF) NAND business for $17.9B, saying he would not be surprised if Broadcom were in fact a bidder but he is not sure if a deal will happen. Depending on the structure of a deal, his pro forma scenarios range from 3% EPS accretion in FY18 to 9% in FY19 accretion, he tells investors. Chin keeps a Buy rating and $245 price target on Broadcom shares, which slid by 0.6% to close at $220.04 yesterday.
03/17/17
RBCM
03/17/17
NO CHANGE
RBCM
Western Digital likely to acquire Toshiba, says RBC Capital
After multiple media reports stated that the Japanese government probably won;t rescue Toshiba (TOSBF, TOSYY), RBC Capital analyst Amit Daryanani says that the news "greatly increases" the odds of the company being acquired by U.S. entities. He thinks that Western Digital (WDX), in partnership with private equity firms, is the "high probability acquirer" of the company. By undertaking the deal, Western Digital would "further improve its NAND position and drive significant accretion with an upside bias to our $12.00+ EPS scenario," Daryanani wrote. He kept a $90 price target and an Outperform rating on the shares.
TOSBF Toshiba, also use TOSYY
$2.71

0.07 (2.65%)

05/22/17
COWN
05/22/17
NO CHANGE
Target $115
COWN
Outperform
Western Digital most strategic buyer of Flash Ventures, says Cowen
Cowen analyst Timothy Arcuri revisited the likelihood of Western Digital (WDC) acquiring the remaining roughly 50% share of Toshiba (TSOBF) Flash Ventures. He believes the deal would be accretive by 10-15% in 2018 and said they remain the most strategic of buyers for the division. Arcuri views Hynix and Micron (MU) as much less likely bidders due to antitrust review, while any deal with Broadcom (AVGO) would have to most likely be backed by fixed economics with Apple (AAPL) or related to Toshiba's discrete/system LSI assets in a Brocade-like (BRCD) deal. Arcuri reiterated his Outperform rating and $115 price target on Western Digital shares.
06/09/17
NOMU
06/09/17
NO CHANGE
NOMU
Micron has positive read through from Broadcom news, says Nomura Instinet
After meeting with Broadcom's (AVGO) CEO, Nomura analyst Romit Shah thinks that the company tried to buy Toshiba's (TOSBF) NAND flash business. The analyst says that Broadcom's effort should lead investors to question whether Micron (MU) is undervalued. He keeps a $40 price target and Buy rating on the shares.
05/24/17
STFL
05/24/17
NO CHANGE
STFL
Western Digital acquisition of Toshiba could be 10%-15% accretive, says Stifel
After Kyodo News reported that Western Digital (WDC) has offered to buy Toshiba (TOSBF) for about $18B, Stifel analyst Aaron Rakers estimates that the deal could be 10%-15% accretive for Western Digital at that price. He keeps a $120 price target and a Buy rating on Western Digital.
AMZN Amazon.com
$978.31

-31.96 (-3.16%)

06/06/17
WELS
06/06/17
NO CHANGE
WELS
Amazon may be the next threat to drug pricing, says Wells Fargo
After CNBC recently reported that Amazon (AMZN) is considering going into the prescription pharmacy business in the U.S., Wells Fargo surveyed nearly 2,900 U.S. adults and found that 54% of those polled said they would use or would probably use "Amazon Pharmacy." While the e-commerce giant has not confirmed its U.S. pharmacy interest, if it did enter the market analyst David Maris believes it could see fast adoption and "usher in a new age of price transparency." Maris also wonders if pharmacy "may be just the beginning" and if Amazon eyes the "even larger prize" of fully integrated digital healthcare. Publicly traded large-cap pharmaceuticals companies include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Publicly traded retail pharmacy operators include CVS Health (CVS), Walgreens (WBA), Fred's (FRED) and Rite Aid (RAD).
06/06/17
MAXM
06/06/17
NO CHANGE
Target $1300
MAXM
Buy
Maxim sees ten $1T categories open to Amazon, ups target to $1,300
Maxim analyst Tom Forte said that as consumers increasingly interact with Amazon in physical locations, "Amazon.com will become simply Amazon." Forte analyzed 18 market opportunities, including 14 that Amazon is already pursuing and four - credit, gas stations, pharmacy, and travel - that are new, and among them identified ten categories where the global total addressable market exceeds $1T. Given Amazon's opportunity to drive incremental sales growth and "further disrupt the retail sector," Forte raised his price target on the stock to $1,300 from $1,075 and keeps a Buy rating on the name.
06/07/17
MSCN
06/07/17
NO CHANGE
MSCN
Amazon.com Q2 revenues tracking below consensus, says MScience
06/12/17
PIPR
06/12/17
NO CHANGE
Target $1200
PIPR
Overweight
Amazon.com price target raised to $1,200 from $1,050 at Piper Jaffray
Piper Jaffray analyst Michael Olson continues to believe that Amazon.com is the best positioned large cap internet platform for the next five-plus years. He raised his price target for the shares to $1,200 from $1,050 and reiterates an Overweight rating on the name. The stock closed Friday down $31.96, or 3%, to $978.31. An analysis of Google search trends indicates Amazon retail unit growth will likely see little to no deceleration in Q2 relative to the 24% growth experienced in Q1, Olson tells investors in a research note. He believes Amazon retail is tracking for an in-line quarter. The analyst reiterates an Overweight rating on the shares.
GOOG Alphabet
$949.83

-33.58 (-3.41%)

06/09/17
06/09/17
NO CHANGE

Nvidia seen trading 'back to $130' by Citron Research
Citron Research, which has previously been cautious on Nvidia (NVDA), recommends that investors take profits and invest instead in Alphabet (GOOG), which it sees having "exposure to the identical array of 'sexy businesses' with less risk on the downside." Reference Link
06/06/17
JPMS
06/06/17
NO CHANGE
JPMS
Overweight
Criteo selloff on Apple iOS update overdone, says JPMorgan
Criteo (CRTO) dropped 7% yesterday after Apple (AAPL) announced that it will limit ad tracking on desktop browsers with the iOS 11 update, JPMorgan Doug Anmuth tells investors in a research note. The news follows Google's (GOOG, GOOGL) recent announcement that Chrome will stop showing ads on sites that do not meet its ad criteria beginning in 2018, the analyst adds. Anmuth does not expect much financial impact to Criteo from either change in the near term. He believes both Apple and Google will ultimately leave ads up to the end user to manage. The analyst views yesterday's selloff in Criteo shares as overdone and keeps an Overweight rating on the name.
05/31/17
MSCO
05/31/17
NO CHANGE
Target $305
MSCO
Equal Weight
Tesla seen more widely as 'more than a car company,' says Morgan Stanley
Morgan Stanley analyst Adam Jonas said he believes the market is increasingly viewing Tesla (TSLA) as "more than a car company," giving it a low chance of success of disrupting a $10T global market for mobility rather than a high chance of success in the smaller traditional light vehicle market. There is "little doubt that Tesla has a seat at the table" for any conversation about machine learning and the multi-trillion-dollar transport market alongside Amazon (AMZN), Alphabet (GOOG), and Apple (AAPL), though its market cap is only a fraction of theirs, Jonas tells investors. The analyst, who added that the firm is getting a "surprisingly high level of pushback" on its prior work on Google's self-driving Waymo unit - with some saying they undervalued Waymo and others saying they undervalued Tesla's shared/autonomous mobility efforts - keeps an Equal Weight rating and $305 price target on Tesla shares.
05/23/17
MSCO
05/23/17
NO CHANGE
Target $305
MSCO
Equal Weight
Alphabet's Waymo an emerging competitor to Tesla, says Morgan Stanley
After Morgan Stanley's Internet team, led by analyst Brian Nowak, said they view the partnership that Waymo, Alphabet's (GOOG) autonomous driving unit, has struck with Lyft as an important step in the "Other Bet" company's ability to help drive the autonomous transition, analyst Adam Jonas said the Waymo/Lyft partnership is an emerging competitor to Tesla (TSLA) in autonomous mobility. Jonas keeps an Equal Weight rating and $305 price target on Tesla shares.
GOOGL Alphabet Class A
$970.12

-34.16 (-3.40%)

MSFT Microsoft
$70.32

-1.63 (-2.27%)

05/25/17
RBCM
05/25/17
NO CHANGE
RBCM
Microsoft named a favorite large cap software idea at RBC Capital
RBC Capital analyst MAtthew Hedberg named Microsoft one of his favorite large cap software ideas. The analyst expects the company to benefit from strong sales of its Azure and Office 365 products, as well as more efficient spending and increased commercial cloud margins.
05/11/17
BMOC
05/11/17
NO CHANGE
BMOC
Microsoft statements positive, says BMO Capital
After attending Microsoft's Analyst Day, BMO Capital analyst Keith Bachman says that Microsoft's " tone and confidence on competencies, culture, products, and opportunities were very bullish." The analyst says that some of the company's comments indicate that its fiscal 2018 results could miss expectations, but he's more upbeat on the company's longer term outlook and thinks that its operating income will increase around 5% in fiscal 2018, enabling the stock's multiple to rise. He keeps a $75 price target and Outperform rating on the shares.
05/15/17
BERN
05/15/17
NO CHANGE
BERN
Microsoft poised to benefit from cybersecurity developments, says Bernstein
Bernstein analyst Pierre Ferragu expects the WannaCry cyber attack to cause more companies to upgrade to newer versions of Microsoft's operating system, thereby benefiting the company. The analyst adds that the company could benefit from the federal government's inxreased usage of the cloud in the wake of President Trump's executive order on cybersecurity.
05/23/17
MAXM
05/23/17
NO CHANGE
Target $41
MAXM
Buy
Nutanix pact with IBM potentially more powerful than Dell deal, says Maxim
Maxim analyst Nehal Chokshi said he views Nutanix' (NTNX) announcement of a multi-year initiative that will combine IBM's (IBM) P-series servers and Nutanix' Enterprise Cloud Platform as a "very significant mid-term positive." He believes the partnership gives IBM a powerful infrastructure software answer to VMware (VMW) and Microsoft (MSFT) and sees the relationship with the potential to be even more powerful than the Dell relationship that powered Nutanix' improving FY16 sales productivity and cash flow. Chokshi keeps a Buy rating on Nutanix but trimmed his price target to $41 from $42 to account for Dell siphoning Nutanix leads to VMware, as previously discussed.
CSCO Cisco
$31.37

-0.24 (-0.76%)

06/05/17
NEED
06/05/17
NO CHANGE
Target $50
NEED
Buy
Gigamon worth $50-$55 per share to acquirer, says Needham
After Reuters reported that Gigamon (GIMO) has responded to Elliot Management's urging and has undertaken an active review of its options, including a potential sale, Needham analyst Alex Henderson estimated that a fair value for Gigamon is in the $50-$55 range. Henderson - who lists Cisco (CSCO), Juniper (JNPR), F5 (FFIV), HP (HPE), Dell/EMC (EMC), Palo Alto (PANW), and Fortinet (FTNT) among the companies that he thinks could be interested - said he would not be surprised to see Gigamon attract multiple suitors. He raised his price target on Gigamon to $50 from $34 and keeps a Buy rating on the stock.
06/05/17
CHLM
06/05/17
NO CHANGE
Target $12.5
CHLM
Buy
Extreme Networks set to enter top 3 in enterprise networking, says Craig-Hallum
Craig-Hallum analyst Christian Schwab noted that Extreme Networks (EXTR) is poised to become the third largest enterprise networking vendor - behind Cisco (CSCO) and HP Enterprise (HPE) - post the closing of its deals with Avaya and Brocade (BRCD). Management has introduced a FY18 target for revenue of over $1B and, combined with its just revealed margin targets, Extreme should be earning 90c-95c per share annually, estimated Schwab, who reiterates his Buy rating and $12.50 price target on the stock following the company's analyst day.
06/02/17
OPCO
06/02/17
NO CHANGE
Target $160
OPCO
Outperform
Arista Networks legal risk is dissipating, says Oppenheimer
Oppenheimer analyst Ittai Kidron says Arista Networks' (ANET) legal risk is dissipating after the Patent and Trial Appeal Board yesterday issued a final decision invalidating all relevant claims of one of the Cisco (CSCO) patents involved in the ongoing Arista/Cisco litigation. This follows a May 25 PTAB decision invalidating a different Cisco patent. Taken together, these decisions are a positive for Arista, Kidron tells investors in a research note. He believes the invalidation of these patents eliminates the infringement and the need to develop workarounds. The analyst keeps an Outperform rating on Arista shares with a $160 price target.
06/01/17
WELS
06/01/17
NO CHANGE
WELS
Arista Networks wins another critical victory against Cisco, says Wells Fargo
Wells Fargo said Arista Networks (ANET) won another critical victory against Cisco (CSCO) in the '945 ITC patent case. The US Patent Trial and Appeal Board invalidated Cisco's '668 patent, which was one of the two patents in the '945 case Arista was found to violated. The firm's analyst said Arista no longer faces a potential injunction that would have prevented it from importing international components and or systems, eliminates the need for workarounds, and prevents Cisco from suing Arista for monetary damages.

TODAY'S FREE FLY STORIES

BRFS

BRF S.A.

$12.77

-0.16 (-1.24%)

18:06
11/22/17
11/22
18:06
11/22/17
18:06
Hot Stocks
BRF S.A. names Jose Aurelio Drummond Jr. as CEO »

BRF S.A. hereby informs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SU

Suncor

$35.42

0.2 (0.57%)

18:02
11/22/17
11/22
18:02
11/22/17
18:02
Hot Stocks
Suncor closes sale of equity interest in East Tan Farm, redeems $750M in debt »

Suncor successfully…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

SAP

SAP

$113.85

-1.44 (-1.25%)

17:53
11/22/17
11/22
17:53
11/22/17
17:53
Periodicals
SAP launches investigation of sales practices in Gulf region, Reuters reports »

SAP has launched a formal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$180.87

-0.99 (-0.54%)

17:47
11/22/17
11/22
17:47
11/22/17
17:47
Periodicals
Facebook tool to show users which content was Russian propaganda, says Bloomberg »

Facebook will add a tool…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSX

CSX

$51.01

0.79 (1.57%)

17:24
11/22/17
11/22
17:24
11/22/17
17:24
Periodicals
CSX to charge more fees on customers that disregard shipping rules, Reuters says »

Starting on January 1st,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

AYTU

Aytu BioScience

$3.03

0.4301 (16.54%)

17:10
11/22/17
11/22
17:10
11/22/17
17:10
Syndicate
Breaking Syndicate news story on Aytu BioScience »

Aytu BioScience files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EPIX

ESSA Pharma

$0.27

0.0059 (2.27%)

17:09
11/22/17
11/22
17:09
11/22/17
17:09
Hot Stocks
ESSA Pharma to begin trading on TSX Venture Exchange »

ESSA Pharma is listing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRDN

Meridian Waste Solutions

$1.69

0.0101 (0.60%)

16:55
11/22/17
11/22
16:55
11/22/17
16:55
Syndicate
Breaking Syndicate news story on Meridian Waste Solutions »

Meridian Waste Solutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APD

Air Products

$161.62

-0.67 (-0.41%)

16:50
11/22/17
11/22
16:50
11/22/17
16:50
Syndicate
Breaking Syndicate news story on Air Products »

Air Products files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOOT

Boot Barn

$13.49

-0.23 (-1.68%)

16:49
11/22/17
11/22
16:49
11/22/17
16:49
Syndicate
Breaking Syndicate news story on Boot Barn »

Boot Barn files $300M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SD

SandRidge Energy

$17.50

0.88 (5.29%)

, BCEI

Bonanza Creek

$32.14

0.46 (1.45%)

16:44
11/22/17
11/22
16:44
11/22/17
16:44
Hot Stocks
Icahn reports 13.51% stake in SandRidge Energy, intends to vote against Bonanza »

Icahn has read Fir Tree…

SD

SandRidge Energy

$17.50

0.88 (5.29%)

BCEI

Bonanza Creek

$32.14

0.46 (1.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SD

SandRidge Energy

$17.50

0.88 (5.29%)

16:35
11/22/17
11/22
16:35
11/22/17
16:35
Hot Stocks
Icahn reports 13.51% stake in SandRidge Energy, intends to vote against Bonanza »

Icahn agrees with Fir…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYMC

Symantec

$28.43

0.32 (1.14%)

, AMZN

Amazon.com

$1,156.16

16.67 (1.46%)

16:32
11/22/17
11/22
16:32
11/22/17
16:32
Hot Stocks
Symantec selects Amazon Web Services to deliver cloud security »

Amazon Web Services, an…

SYMC

Symantec

$28.43

0.32 (1.14%)

AMZN

Amazon.com

$1,156.16

16.67 (1.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 18

    Mar

16:30
11/22/17
11/22
16:30
11/22/17
16:30
Options
Preliminary option volume of 13.6M today »

Preliminary option volume…

AMZN

Amazon.com

$1,156.16

16.67 (1.46%)

16:26
11/22/17
11/22
16:26
11/22/17
16:26
Hot Stocks
Amazon Web Services announces Amazon ML Solutions Lab program »

Amazon Web Services, Inc…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

NRIM

Northrim BanCorp

$34.75

-0.25 (-0.71%)

16:22
11/22/17
11/22
16:22
11/22/17
16:22
Hot Stocks
Northrim BanCorp announces CFO transition »

Northrim BanCorp is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,156.16

16.67 (1.46%)

, CERN

Cerner

$70.03

3.35 (5.02%)

16:21
11/22/17
11/22
16:21
11/22/17
16:21
General news
On The Fly: Top stock stories for Wednesday »

Stocks opened in positive…

AMZN

Amazon.com

$1,156.16

16.67 (1.46%)

CERN

Cerner

$70.03

3.35 (5.02%)

HPE

HP Enterprise

$13.10

-1.02 (-7.22%)

HPQ

HP Inc.

$21.34

-1.12 (-4.99%)

DE

Deere

$145.25

6.02 (4.32%)

ROK

Rockwell Automation

$191.02

-2 (-1.04%)

EMR

Emerson

$61.88

1.53 (2.54%)

AKZOY

AkzoNobel

$31.04

0.475 (1.55%)

AXTA

Axalta Coating

$35.50

1.63 (4.81%)

GME

GameStop

$17.37

0.64 (3.83%)

GES

Guess

$15.62

-2.33 (-12.98%)

IRBT

iRobot

$68.50

-4.57 (-6.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

  • 27

    Nov

  • 28

    Nov

  • 28

    Nov

  • 11

    Dec

  • 18

    Mar

CHMI

Cherry Hill Mortgage

$18.51

0.06 (0.33%)

16:21
11/22/17
11/22
16:21
11/22/17
16:21
Syndicate
Breaking Syndicate news story on Cherry Hill Mortgage »

Cherry Hill Mortgage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKTR

Nektar

$49.75

-0.23 (-0.46%)

16:20
11/22/17
11/22
16:20
11/22/17
16:20
Hot Stocks
Nektar names new CRDO, CMO and CSO »

Nektar announced several…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

16:20
11/22/17
11/22
16:20
11/22/17
16:20
Options
Closing CBOE SPX and VIX Index summary for November 22nd »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VGZ

Vista Gold

$0.68

0.0069 (1.03%)

16:18
11/22/17
11/22
16:18
11/22/17
16:18
Syndicate
Vista Gold enters $10M ATM agreement with H.C. Wainwright & Co. »

Vista Gold announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPX

GP Strategies

$23.50

-0.2 (-0.84%)

16:17
11/22/17
11/22
16:17
11/22/17
16:17
Hot Stocks
GP Strategies announces $10M share repurchase increase »

GP Strategies Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 30

    Nov

$NSD

NASDAQ Market Internals

16:17
11/22/17
11/22
16:17
11/22/17
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPX

GP Strategies

$23.50

-0.2 (-0.84%)

16:16
11/22/17
11/22
16:16
11/22/17
16:16
Hot Stocks
GP Strategies names Michael Dugan as new CFO »

Global performance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 30

    Nov

$NYE

NYSE Market Internals

16:16
11/22/17
11/22
16:16
11/22/17
16:16
Technical Analysis
NYSE market internals summary »

Volume was below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.